Angiotensin Receptor Blockers for COVID-19: Pathophysiological and Pharmacological Considerations About Ongoing and Future Prospective Clinical Trials

COVID-19 pandemic demands a swift response to find therapeutic tools that effectively reduce morbidity and mortality. Despite initial fears, evidence from retrospective observational studies supports the inhibition of the renin-angiotensin system as an emerging pathway to delay or moderate angiotens...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Front Pharmacol
Hauptverfasser: Rothlin, Rodolfo Pedro, Duarte, Mariano, Pelorosso, Facundo Germán, Nicolosi, Liliana, Salgado, M. Victoria, Vetulli, Héctor Miguel, Spitzer, Eduardo
Format: Artigo
Sprache:Inglês
Veröffentlicht: Frontiers Media S.A. 2021
Schlagworte:
Pharmacology
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8039444/
https://ncbi.nlm.nih.gov/pubmed/33854432
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2021.603736
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge